These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1357648)

  • 21. [Significance of topical therapy in clinical situations. Location-dependent principles].
    von Stebut E
    Hautarzt; 2014 Mar; 65(3):186-91. PubMed ID: 24419475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vivo assessment of the cutaneous bioavailability of topically applied maxacalcitol.
    Ikeda Y; Hirata K; Kano S; Yanagihara H; Takahara J; Kondo K; Umemura K
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):305-10. PubMed ID: 16082417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The topical treatment of psoriasis.
    van de Kerkhof PC
    Clin Exp Dermatol; 2005 Mar; 30(2):205-8. PubMed ID: 15725262
    [No Abstract]   [Full Text] [Related]  

  • 24. Topical delivery systems for azelaic acid: effect of the suspended drug in microemulsion.
    Pattarino F; Carlotti ME; Gasco MR
    Pharmazie; 1994 Jan; 49(1):72-3. PubMed ID: 8140138
    [No Abstract]   [Full Text] [Related]  

  • 25. The critical role of the vehicle to therapeutic efficacy and patient compliance.
    Piacquadio D; Kligman A
    J Am Acad Dermatol; 1998 Aug; 39(2 Pt 3):S67-73. PubMed ID: 9703127
    [No Abstract]   [Full Text] [Related]  

  • 26. A novel foam vehicle for delivery of topical corticosteroids.
    Huang X; Tanojo H; Lenn J; Deng CH; Krochmal L
    J Am Acad Dermatol; 2005 Jul; 53(1 Suppl 1):S26-38. PubMed ID: 15968261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Topical methotrexate delivered by iontophoresis in the treatment of recalcitrant psoriais--a case report.
    Tiwari SB; Kumar BC; Udupa N; Balachandran C
    Int J Dermatol; 2003 Feb; 42(2):157-9. PubMed ID: 12709009
    [No Abstract]   [Full Text] [Related]  

  • 28. Acne maintenance therapy: expanding the role of topical retinoids?
    Zane LT
    Arch Dermatol; 2006 May; 142(5):638-40. PubMed ID: 16702503
    [No Abstract]   [Full Text] [Related]  

  • 29. Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata.
    Jang YH; Jung HJ; Moon SY; Lee WJ; Lee SJ; Lee WK; Kim DW
    J Am Acad Dermatol; 2017 Jul; 77(1):170-172.e1. PubMed ID: 28619558
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of aerosol preparations in external therapy of patients with eczema].
    Somov BA; Ivanov VV
    Vestn Dermatol Venerol; 1974 Oct; 0(10):52-4. PubMed ID: 4432617
    [No Abstract]   [Full Text] [Related]  

  • 31. Safe and effective application of topical treatments to the skin.
    Lawton S
    Nurs Stand; 2013 Jun 19-25; 27(42):49-56; quiz 58, 60. PubMed ID: 23930532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Adherence: definitions and measurement methods: characteristics of adherence to topical treatments].
    Halioua B
    Ann Dermatol Venereol; 2012 Jan; 139 Suppl 1():S1-6. PubMed ID: 22305280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Advancements in Topical Antifungal Vehicles.
    Kircik LH
    J Drugs Dermatol; 2016 Feb; 15(2 Suppl):s44-8. PubMed ID: 26885798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical trials in dermatology. Evaluation of the tolerability and efficacy of a topical anti-acne].
    Verschoore M; Poncet M; Schaefer H; Revuz J; De Prost Y; Guillaume JC; Ortonne JP; Czernielewski J
    Therapie; 1991; 46(3):189-91. PubMed ID: 1838841
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical-therapeutic evaluation of a new dermatologic preparation for topical use with a base of alcyonide and neomycin].
    Cappelletti E; Cristofolini M
    Riv Eur Sci Med Farmacol; 1987 Sep; 9(3):335-40. PubMed ID: 3508609
    [No Abstract]   [Full Text] [Related]  

  • 36. Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents.
    Krejci-Manwaring J; McCarty MA; Camacho F; Carroll CL; Johnson K; Manuel J; Balkrishnan R; Hartle J; Fleischer A; Feldman SR
    J Am Acad Dermatol; 2006 May; 54(5 Suppl):S235-6. PubMed ID: 16631951
    [No Abstract]   [Full Text] [Related]  

  • 37. Topical agents for the skin: efficacy and safety.
    Br Med J (Clin Res Ed); 1985 Sep; 291(6496):665. PubMed ID: 3928072
    [No Abstract]   [Full Text] [Related]  

  • 38. [Composition of topical drugs].
    Zerrouk N; Arnaud P
    Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S27-9. PubMed ID: 17563711
    [No Abstract]   [Full Text] [Related]  

  • 39. Galenical principles in skin protection.
    Zhang J; Smith EW; Surber C
    Curr Probl Dermatol; 2007; 34():11-18. PubMed ID: 17312353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks.
    Qureshi AA; Fischer MA
    Arch Dermatol; 2006 May; 142(5):633-7. PubMed ID: 16702502
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.